CI vs SERA · P/E 2.4, rev $274.90B vs rev $77.0K
Cigna Corp (CI) versus Sera Prognostics Inc (SERA) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Sera Prognostics Inc (SERA) is a medical devices company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported SERA revenue for 2024-12-31 was $77.0K. Net income was -$32.9M. Revenue was down 74.8% from 2023-12-31 to 2024-12-31. SERA currently screens at market cap $89.1M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. SERA currently screens at market cap $89.1M.
Not investment advice. Open the CI and SERA stock pages for the full models.
Not investment advice.